| 51 |
25096410 | Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review. | 2014 Aug 5 |
5 |
| 52 |
22841520 | The effect of metformin on monocyte secretory function in simvastatin-treated patients with impaired fasting glucose. | 2013 Jan |
1 |
| 53 |
23526220 | Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. | 2013 Aug |
2 |
| 54 |
23611575 | A successful case of pain management using metformin in a patient with adiposis dolorosa. | 2013 Jun |
1 |
| 55 |
23659985 | Maternal metformin treatment decreases fetal inflammation in a rat model of obesity and metabolic syndrome. | 2013 Aug |
1 |
| 56 |
24399727 | Monocyte-suppressing effect of high-dose metformin in fenofibrate-treated patients with impaired glucose tolerance. | 2013 |
1 |
| 57 |
23091851 | [Pharmacogenetic features of the effect of metformin in patients with coronary heart disease in the presence of metabolic syndrome and type 2 diabetes mellitus in terms of PPAR-gamma2 gene polymorphism]. | 2012 |
1 |
| 58 |
20956498 | OCT1 Expression in adipocytes could contribute to increased metformin action in obese subjects. | 2011 Jan |
1 |
| 59 |
21031343 | Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. | 2011 Feb |
1 |
| 60 |
21424914 | The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus. | 2011 Dec |
1 |
| 61 |
21774820 | Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation. | 2011 Jul 20 |
1 |
| 62 |
21801267 | Interleukin-6 as an early chronic inflammatory marker in polycystic ovary syndrome with insulin receptor substrate-2 polymorphism. | 2011 Dec |
1 |
| 63 |
21954641 | [Efficacy of metformin as initial therapy in patients with coronary artery disease and diabetes type 2]. | 2011 Jan-Mar |
1 |
| 64 |
20652679 | AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3). | 2010 Nov |
2 |
| 65 |
20730705 | Treatment of polycystic ovary syndrome (PCOS) with metformin ameliorates insulin resistance in parallel with the decrease of serum interleukin-6 concentrations. | 2010 Oct |
6 |
| 66 |
18597869 | Metformin inhibits TNF-alpha-induced IkappaB kinase phosphorylation, IkappaB-alpha degradation and IL-6 production in endothelial cells through PI3K-dependent AMPK phosphorylation. | 2009 May 15 |
4 |
| 67 |
18820825 | Pioglitazone reduces monocyte activation in type 2 diabetes. | 2009 Mar |
1 |
| 68 |
19188739 | Determinants of interleukin-6 and C-reactive protein vary in polycystic ovary syndrome, as do effects of short- and long-term metformin therapy. | 2009 |
2 |
| 69 |
19494326 | Metformin attenuated the autoimmune disease of the central nervous system in animal models of multiple sclerosis. | 2009 Jun 15 |
1 |
| 70 |
18082089 | [Rosuvastatin and metformin decrease inflammation and oxidative stress in patients with hypertension and dyslipidemia]. | 2007 Dec |
1 |
| 71 |
16385087 | Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells. | 2006 Mar |
1 |